Rinvoq LQ Interactions
There are 617 drugs known to interact with Rinvoq LQ (upadacitinib), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 382 are major, 225 are moderate, and 10 are minor.
- View all 617 medications that may interact with Rinvoq LQ
- View Rinvoq LQ alcohol/food interactions (2)
- View Rinvoq LQ disease interactions (9)
Most frequently checked interactions
View interaction reports for Rinvoq LQ (upadacitinib) and the medicines listed below.
- acarbose
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- albuterol
- Alhemo (concizumab)
- Allegra (fexofenadine)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- amoxicillin / clavulanate
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Arava (leflunomide)
- Astepro (azelastine nasal)
- atomoxetine
- atorvastatin
- Cymbalta (duloxetine)
- Humira (adalimumab)
- montelukast
- Nurtec ODT (rimegepant)
- Qulipta (atogepant)
- Vitamin D3 (cholecalciferol)
Rinvoq LQ alcohol/food interactions
There are 2 alcohol/food interactions with Rinvoq LQ (upadacitinib).
Rinvoq LQ disease interactions
There are 9 disease interactions with Rinvoq LQ (upadacitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- cytopenias
- gastrointestinal perforation
- hepatic impairment
- hyperlipidemia
- vaccination
Report options
QR code containing a link to this page
More about Rinvoq LQ (upadacitinib)
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
